VCM
NXTM

Versant Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Versant Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-26
Closed – – 1852
2018
Q4 		$0 Hold
26
– – ﹤0.01% 1749
2018
Q3 		$0 Hold
26
– – ﹤0.01% 1732
2018
Q2 		$0 Hold
26
– – ﹤0.01% 1720
2018
Q1 		$0 Hold
26
– – ﹤0.01% 1749
2017
Q4 		$0 Hold
26
– – ﹤0.01% 1713
2017
Q3 		$0 Hold
26
– – ﹤0.01% 1644
2017
Q2 		$0 Hold
26
– – ﹤0.01% 1615
2017
Q1 		$0 Hold
26
– – ﹤0.01% 1604
2016
Q4 		$0 Hold
26
– – ﹤0.01% 1606
2016
Q3 		$0 Sell
26
-4
-13% -$93 ﹤0.01% 1561
2016
Q2 		$0 Hold
30
– – ﹤0.01% 1514
2016
Q1 		$0 Hold
30
– – ﹤0.01% 1535
2015
Q4 		$0 Buy
+30
New +$559 ﹤0.01% 1476

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Versant Capital Management's NXTM Position: Q1 2019 in Review

Versant Capital Management sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 26 shares.

Versant Capital Management first reported a position in NXTM in Q4 2015 and held it in 13 quarters. The position peaked at $0 in Q4 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Versant Capital Management reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Versant Capital Management sold 26 NxStage Medical Inc. shares in Q1 2019.
  • Versant Capital Management first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 13 quarters.
  • Versant Capital Management's NxStage Medical Inc. position peaked at $0 in Q4 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Versant Capital Management's 13F filing for Q1 2019, filed 23 Apr 2019.